Director, Commercial Strategy
Regeneron Pharmaceuticals
Summary
The Director, Commercial Strategy, is part of a high-performing team helping drive current and future Commercial opportunities for Regeneron. Reporting to the VP, Commercial Strategy, the successful candidate will partner with cross-functional teams to identify, prioritize, innovate and refine strategies and best practices across the business, while anticipating future business needs and mitigating complex global environments.
Job description
When & where
- In the Sleepy Hollow, NY Office for 4 days a week
Discover your role
This position will be primarily responsible for the following activities:
- Spearhead work to evolve Commercial brand planning processes
- Act as central facilitator for key Commercial collaborative groups, including the Commercial Digital and Privacy Working Group
- Support cross-Commercial collaboration on strategic digital/social governance and innovation, including initiatives that address the changing privacy landscape and vendor efficiencies
- Prepare high-impact presentations for executive leadership and governance bodies
- Understand and leverage trends in the marketplace and competitive benchmarking to inform strategies for relevant programs, and keep abreast of insights and external advances to reach customers across the commercial biopharmaceutical ecosystem
- Ensure cost effective delivery of programs, including tracking and monitoring KPIs based on individual/project goals
In collaboration with the VP, Commercial Strategy, this role will also participate in the following activities:
- Identify and develop annual strategic plans for the Commercial organization
- Partner with Commercial Business Units (CBUs) to drive cross-portfolio strategies and operational effectiveness for in-line brands, with the ultimate objective of helping appropriate patients access and continue to benefit from Regeneron's medicines
- Support cross-functional global product launch efforts to drive best practice learnings, including launch readiness, uptake optimization and post-launch product performance
- Provide support and expertise for CBUs as they prepare for anticipated market events, including gap assessments, scenario plans, war games, analogues/benchmarks and measurement
- Collaborate with cross-functional partners to plan for and implement priority business initiatives to drive longer-term growth (incl. corporate planning, Business Development assessments and ad-hoc projects)
- In collaboration with Human Resources, identify key Commercial talent needs, and champion learning and development opportunities
Requirements
- BA/BS required, MBA or advanced degree (PhD, MD) preferred
- Minimum years of experience: 12+ with Bachelors, 10+ with Masters and 8+ with PhD/Doctorate
- At least 7 years of industry experience working with one or more publicly listed biopharmaceutical company, with a successful track record in strategy, management consulting, brand management and/or marketing
- Experience working with pre-launch, launch and/or on-market biopharmaceutical commercial teams
- Deep understanding of commercial, legal and regulatory landscape governing communications for pre-approval and post-approval pharmaceutical products
Benefits
- Annual bonuses
- Incentive plans
- Equity awards
- Pension or retirement benefits
- 401(k) company match
- Health and wellness programs
- Fitness centers
- Insurance benefits
- Paid time off
- Family support benefits
Company overview
Regeneron Pharmaceuticals is a leading American biotechnology company founded in 1988 and headquartered in Tarrytown, New York. The company specializes in inventing, developing, and commercializing life-transforming medicines for people with serious diseases. Regeneron is renowned for its innovative antibody technologies and has developed several groundbreaking therapies, including EYLEA® for retinal diseases, DUPIXENT® for inflammatory conditions, and the COVID-19 antibody cocktail REGEN-COV®. The company operates with a strong focus on research and development across multiple therapeutic areas including ophthalmology, oncology, cardiovascular diseases, and rare genetic disorders. Regeneron's proprietary VelocImmune® technology platform enables the rapid generation of fully human monoclonal antibodies. With over 15,000 employees globally and annual revenues exceeding $14 billion, Regeneron has established itself as a major force in the biotechnology industry, consistently ranking among the top-performing pharmaceutical companies and maintaining a robust pipeline of investigational therapies.